Huawei Says It Will Not Make Drugs, Aiming to Be Computing Base for AI Drug Discovery
The head of Huawei's pharmaceutical business unit said the company will not develop drugs or pipelines, instead supplying computing, storage, networking and tools for AI drug discovery.
Read the full story at Pandaily ↗
Timeline · 1 report
- 2026-10-30 02:01 · Pandaily
Huawei Says It Will Not Make Drugs, Aims to Be the Computing Base for AI Drug Discovery
More stories
- Malicious Claude Code extension on Cursor marketplace exposed up to 5,000 developers — Microsoft Research Blog
- Mistral releases weights for trillion-parameter 'Le Chonk' model — Mistral AI News
- S&P Revises Meta's Credit Outlook to Negative on AI Spending Concerns — Bloomberg AI
- Anthropic files for blockbuster IPO as Blackstone flags likely junk rating — Fast Company AI
- OpenAI, Google, Microsoft and Anthropic to honor shared robots.txt opt-out for AI training — OpenAI News
- OpenAI cuts funding target by $10 billion, now seeking $20 billion at $1.25 trillion valuation — Financial Times AI
- Google unveils Gemini 4 Carbon, a cybersecurity-focused frontier model — Google DeepMind Blog
- Google says AI search features are reducing search revenue as Q3 losses widen — Ars Technica AI
Get the daily brief of stories like this at 6:30 every morning →